Publications - 'F'
Publications 401 - 425 de 1212
| Titre | DOI |
|---|---|
|
Film programming: curating for cinemas, festivals, archives M.C. Hayes 2016 |
10.1080/01439685.2016.1164482 |
|
Films without images: a history of unrealized scenarios of `The human Condition' J. Loehr 2016 |
10.1093/fs/knw014 |
|
Final analysis of COMET-1: Cabozantinib (Cabo) versus prednisone (Pred) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) previously treated with docetaxel (D) and abiraterone (A) and/or enzalutamide (E). M.Raymond Smith; J.Sebastian De Bono; C.N. Sternberg; S. Le Moulec; S. Oudard; U. De Giorgi; M. Krainer; A.M. Bergman; W. Hoelzer; R. De Wit; M. Boegemann; F. Saad; G. Cruciani; A. Thiery-Vuillemin; S. Feyerabend; K. Miller; D.Albert Ramies; C. Hessel; A. Weitzman; K. Fizazi 2015 |
10.1200/jco.2015.33.7_suppl.139 |
|
Final Analysis of the ALFA 0701 Study S. Castaigne; C. Pautas; C. Terre; A. Renneville; C. Gardin; F. Suarez; D. Caillot; C. Berthon; P. Rousselot; C. Preudhomme; L. Morisset; K.Celli Lebras; S. Chevret; H. Dombret 2014 |
|
|
Final Analysis of the ALFA 0701 Study S. Castaigne; C. Pautas; C. Terre; A. Renneville; C. Gardin; F. Suarez; D. Caillot; C. Berthon; P. Rousselot; C. Preudhomme; L. Morisset; K.Celli Lebras; S. Chevret; H. Dombret 2014 |
|
|
Final Analysis of the RO-CHOP Phase Ib/II Study: Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphoma (PTCL) J. Dupuis; F. Morschhauser; H. Ghesquieres; H. Tilly; O. Casasnovas; S. Amorim; V. Ribrag; B. Coiffier 2014 |
|
|
Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer R. Bell; J. Brown; M. Parmar; M. Toi; T. Suter; G.G. Steger; X. Pivot; J. Mackey; C. Jackisch; R. Dent; P. Hall; N. Xu; L. Morales; L. Provencher; R. Hegg; L. Vanlemmens; A. Kirsch; A. Schneeweiss; N. Masuda; F. Overkamp; D. Cameron 2017 |
10.1093/annonc/mdw665 |
|
Final efficacy results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer R. Bell; J. Brown; M. Parmar; M. Toi; T. Suter; G. Steger; X. Pivot; J. Mackey; C. Jackisch; R. Dent; P. Hall; A. Mecke; L. Morales; L. Provencher; E. Staroslawska; R. Hegg; L. Vanlemmens; A. Kirsch; A. Schneeweiss; N. Masuda; F. Overkamp; D. Cameron 2015 |
10.1158/1538-7445.SABCS14-PD2-2 |
|
Final overall survival (OS) analysis of PROfound: Olaparib vs physician's choice of enzalutamide or abiraterone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations J.S. de Bono; J. Mateo; K. Fizazi; F. Saad; N. Shore; S. Sandhu; K.N. Chi; O. Sartor; N. Agarwal; D. Olmos; A. Thiery-Vuillemin; P. Twardowski; G. Roubaud; M. Ozguroglu; J. Kang; J. Burgents; C. Gresty; C. Corcoran; C.A. Adelman; M. Hussain 2020 |
10.1016/j.annonc.2020.08.870 |
|
Final results from the randomized CABADOC trial: Patient preference between cabazitaxel and docetaxel for first-line chemotherapy in metastatic castrate-resistant prostate cancer (mCRPC). G. Baciarello; R. Delva; G. Gravis; Y. Tazi; C. Theodore; M. Gross-Goupil; E. Bompas; F. Joly; T. Lharidon; T.Nguyen Tan Hon; P. Barthelemy; S. Culine; J.Francois Berdah; M. Deblock; P. Beuzeboc; A. Flechon; C. Cheneau; G. Martineau; I. Borget; K. Fizazi 2019 |
10.1200/JCO.2019.37.15_suppl.5017 |
|
Final results fronts the phase I study expansion cohort of Dehio0932, an oral HSP90 inhibitor, in patients with solid tumors. P. Fumoleau; J.C. Soria; J.P. Delord; R. Belli; S. Brienza; C. Zanna; A. Destaillats; E. Rouits; A. Hollebecque; A. Gazzah; N. Isambert 2014 |
10.1200/jco.2014.32.15_suppl.2550 |
|
Final results of a phase I study evaluating INVAC-1, a novel DNA vaccine expressing an inactive form of human telomerase reverse transcriptase (hTERT) in patients with advanced solid tumors. L. Teixeira; J. Medioni; L. Doucet; A. Angelergues; S. Culine; S. Oudard; M. Brizard; Z. Ghrieb; O. Adotevi; C. Laheurte; M.A.Dragon Durey; P. Laurent-Puig; J.J. Kiladjian; S. wain-Hobson; V. Doppler; R. DeFrance; J. Garibal; T. Huet; P.Langlade Demoyen 2019 |
10.1200/JCO.2019.37.15_suppl.2642 |
|
Final results of a prospective multicenter phase II study using Busulfan AUC intensification in AML patients undergoing allogeneic HSCT in first complete remission F. Suarez; P. Bourget; E.P. Alessandrino; A. Bartoli; G. Socie; M. Michallet; J. Bourhis; A. Paci; D. Blaise; A. Berceanu; V. Kemmel; J. Sierra; M.E.Moreno Martinez; A. Amin; A.A. Colombo; A. Xhaard; F.E. Nicolini; X. Thomas; S. Fuerst; B. Lioure; R. Martino; C. Levrault; A. Petain; T.Thanh Minh 2015 |
|
|
Final results of a prospective multicenter phase II study using Busulfan AUC intensification in AML patients undergoing allogeneic HSCT in first complete remission F. Suarez; P. Bourget; E.P. Alessandrino; A. Bartoli; G. Socie; M. Michallet; J. Bourhis; A. Paci; D. Blaise; A. Berceanu; V. Kemmel; J. Sierra; M.E.Moreno Martinez; A. Amin; A.A. Colombo; A. Xhaard; F.E. Nicolini; X. Thomas; S. Fuerst; B. Lioure; R. Martino; C. Levrault; A. Petain; T.Thanh Minh 2015 |
|
|
Final results of a randomized phase II GELA/LYSA study of rituximab plus ACVBP or CHOP, using a PET-driven consolidation strategy, in patients with high-risk diffuse large B-cell lymphoma (DLBCL). R.O. Casasnovas; L. Ysebaert; C. Thieblemont; B. Coiffier; S. Bologna; G. Lepeu; A. Delmer; I. Plantier; J. Gabarre; M. Andre; D. Senecal; C. Fruchart; M. Meignan; A. Berriolo-Riedinger; S. Bardet; T.Jo Molina; J.P. Jais; C. Haioun; H. Tilly; F. Morschhauser 2014 |
10.1200/jco.2014.32.15_suppl.8503 |
|
Final results of PRODIGE 9, a randomized phase III comparing no treatment to bevacizumab maintenance during chemotherapy-free intervals in metastatic colorectal cancer. T. Aparicio; J. Bennouna; K. Le Malicot; F. Ghiringhelli; V. Boige; J. Taieb; O. Bouche; J.Marc Phelip; E. Francois; C. Borel; R. Faroux; J.F. Seitz; S. Jacquot; D. Genet; F. Khemissa; E. Suc; F. Desseigne; P. Texereau; J.L. Jouve 2016 |
10.1200/JCO.2016.34.15_suppl.3531 |
|
Final results of the international randomized PORTEC-3 trial of adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer S.M. de Boer; M.E. Powell; L.R. Mileshkin; D. Katsaros; P. Bessette; C. Haie-Meder; P.B. Ottevanger; J.A. Ledermann; P. Khaw; A. Colombo; A.W. Fyles; M.H. Baron; H.C. Kitchener; H. Nijman; R.F.P.M. Kruitwagen; I.M. Jurgenliemk-Schulz; R.A. Nout; V.T.H.B.M. Smit; H. Putter; C.L. Creutzberg 2017 |
10.1200/JCO.2017.35.15_suppl.5502 |
|
Final results of the multicenter randomized phase II PAZOGIST trial evaluating the efficacy of pazopanib (P) plus best supportive care (BSC) vs BSC alone in resistant unresectable metastatic and/or locally advanced gastrointestinal stromal tumors (GIST) J.Y. Blay; M. Molimard; C. Cropet; J. Domont; M. Toulmonde; E. Bompas; P.Alexandre Cassier; I.Laure Ray-Coquard; M. Rios; A. Adenis; A. Italiano; A. Le Cesne; O. Bouche; O. Mir; F. Duffaud; F. Bertucci; N. Isambert; A. Belleville; J. Gautier; D. Perol 2015 |
|
|
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer E. Vrdoljak; N. Marschner; C. Zielinski; J. Gligorov; J. Cortes; F. Puglisi; M. Aapro; L. Fallowfield; A. Fontana; M. Inbar; Z. Kahan; A. Welt; C. Levy; E. Brain; X. Pivot; C. Putzu; G. Martin; S. de Ducla; V. Easton; G. von Minckwitz 2016 |
10.1093/annonc/mdw316 |
|
Final results of the TANIA randomized phase III trial of bevacizumab (BEV) after progression on 1st-line BEV therapy for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC) E. Vrdoljak; N. Marschner; C. Zielinski; J. Gligorov; J. Cortes; F. Puglisi; M. Aapro; L. Fallowfield; A. Fontana; M. Inbar; Z. Kahan; A. Welt; C. Levy; E. Brain; X. Pivot; C. Putzu; A. Gonzalez-Martin; K. Ebel; V. Easton; G. von Minckwitz 2016 |
10.1158/1538-7445.SABCS15-P6-14-01 |
|
Financial soundness of Islamic banks: does the structure of the board of directors matter? A. Khalil; I. Ben Slimene 2021 |
10.1108/CG-06-2020-0237 |
|
Financial stability and economic performance J. Creel; P. Hubert; F. Labondance 2015 |
10.1016/j.econmod.2014.10.025 |
|
Financial Sustainability of Small- and Medium-Sized Enterprises in the Cultural and Creative Sector: The Role of Funding E. Borin; F. Donato; C. Sinapi 2018 |
10.1007/978-3-319-65506-2_4 |
|
Financing the Huguenot War Effort during the Early Wars of Religion, 1562-1570 H. Daussy 2015 |
10.1215/00161071-3113815 |
|
Finding a cyclide given three contact conditions R. Langevin; J.C. Sifre; L. Druoton; L. Garnier; M. Paluszny 2015 |
10.1007/s40314-014-0116-0 |